Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

FDA approves new indications for Prevacid

Dec. 12, 2000

Phase I trial of new treatment for HCV and associated liver cancer cleared in Israel

Dec. 4, 2000

Nitric oxide synthase inhibitors for inflammation and pain described by AstraZeneca

Nov. 30, 2000

Secondary efficacy measures improved by ISIS-2302 treatment in Crohn's disease

Nov. 30, 2000

New target for IBD treatment discussed at UEGW: leukocyte-platelet aggregation

Nov. 30, 2000

Mechanism of action of thalidomide in Crohn's disease investigated as part of clinical trial

Nov. 30, 2000

Immediate withdrawal of Lotronex in U.S. announced by Glaxo Wellcome

Nov. 29, 2000

Synthetic immunomodulatory peptide inhibits production of proinflammatory cytokines in CD

Nov. 29, 2000

Phytomedicine continues to show promise for GI inflammatory conditions

Nov. 29, 2000

New gastric antisecretory agents patented by Byk Gulden

Nov. 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...